ZLAB
Price:
$30.46
Market Cap:
$3.02B
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; and Qinlock to treat gastrointestinal stromal tumors. It also develops Odronextamab to treat follicular lymphoma, diffuse large B-cell lymphoma, and other B-celllymphomas; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in T...[Read more]
Industry
Biotechnology
IPO Date
2017-09-20
Stock Exchange
NASDAQ
Ticker
ZLAB
According to Zai Lab Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 2.37B. This represents a change of 71.35% compared to the average of 1.38B of the last 4 quarters.
The mean historical Enterprise Value of Zai Lab Limited over the last ten years is 2.94B. The current 2.37B Enterprise Value has changed 7.97% with respect to the historical average. Over the past ten years (40 quarters), ZLAB's Enterprise Value was at its highest in in the June 2021 quarter at 14.72B. The Enterprise Value was at its lowest in in the June 2016 quarter at 0.
Average
2.94B
Median
1.87B
Minimum
254.56M
Maximum
10.09B
Discovering the peaks and valleys of Zai Lab Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 356.59%
Maximum Annual Enterprise Value = 10.09B
Minimum Annual Increase = -80.32%
Minimum Annual Enterprise Value = 254.56M
Year | Enterprise Value | Change |
---|---|---|
2023 | 1.87B | -4.46% |
2022 | 1.95B | -60.11% |
2021 | 4.90B | -51.47% |
2020 | 10.09B | 180.39% |
2019 | 3.60B | 209.55% |
2018 | 1.16B | 356.59% |
2017 | 254.56M | -80.32% |
2016 | 1.29B | -5.19% |
The current Enterprise Value of Zai Lab Limited (ZLAB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.91B
5-year avg
4.48B
10-year avg
2.94B
Zai Lab Limited’s Enterprise Value is greater than C4 Therapeutics, Inc. (396.43M), greater than Erasca, Inc. (649.58M), greater than Cullinan Oncology, Inc. (802.58M), less than Legend Biotech Corporation (8.26B), less than Seagen Inc. (42.84B), less than Alnylam Pharmaceuticals, Inc. (35.37B), less than Ascendis Pharma A/S (7.04B), less than Roivant Sciences Ltd. (0), less than Krystal Biotech, Inc. (3.33B), less than Prometheus Biosciences, Inc. (4.73B), less than Akero Therapeutics, Inc. (9.47B), greater than Apellis Pharmaceuticals, Inc. (1.97B), less than PTC Therapeutics, Inc. (3.52B), less than Blueprint Medicines Corporation (2.85B), less than Intercept Pharmaceuticals, Inc. (6.06B), greater than Madrigal Pharmaceuticals, Inc. (915.81M), less than null (6.71B),
Company | Enterprise Value | Market cap |
---|---|---|
396.43M | $388.98M | |
649.58M | $768.41M | |
802.58M | $914.87M | |
8.26B | $8.13B | |
42.84B | $43.15B | |
35.37B | $35.16B | |
7.04B | $7.18B | |
0 | $8.64B | |
3.33B | $5.07B | |
4.73B | $9.56B | |
9.47B | $2.24B | |
1.97B | $3.41B | |
3.52B | $3.11B | |
2.85B | $5.76B | |
6.06B | $794.69M | |
915.81M | $6.94B | |
6.71B | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zai Lab Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Zai Lab Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Zai Lab Limited's Enterprise Value?
What is the highest Enterprise Value for Zai Lab Limited (ZLAB)?
What is the 3-year average Enterprise Value for Zai Lab Limited (ZLAB)?
What is the 5-year average Enterprise Value for Zai Lab Limited (ZLAB)?
How does the current Enterprise Value for Zai Lab Limited (ZLAB) compare to its historical average?